Citius Oncology Inc (TENKU) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TENKU Annual Balance Sheets →
Balance sheet patterns shown here provide context for understanding Citius Oncology Inc's financial stability and long-term positioning.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent16.56
Cash & Short-term Investments16.00
Accounts receivable0.69
Inventories22.63
Other Current Assets0.00
Prepaid Expense, Current AS2.83
Total Current Assets42.71
Deferred Costs, Noncurrent AS3.59
Other Assets, Noncurrent65.80
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Inprocess Research And Development Noncurrent71.11
Total Assets112.09
Liabilities
Accounts Payable, Current AC7.32
Accrued Liabilities, Current AC25.84
Other Notes Payable, Current OT0.00
Other Liabilities, Current0.00
Total Current Liabilities58.79
Long-term debt16.41
Total Long-term Debt16.41
Other liabilities, Noncurrent22.15
DeferredIncomeTaxLiabilitiesNet2.82
License Payable17.65
Total Liabilities71.71
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock145.48
Retained Earnings / Accumulated Deficit-105.11
Other Equity0.00
Common Stockholder's Equity40.38
Total Stockholder's Equity40.38
Liabilities & Stockholder's Equity112.09
4 historic quarters locked

Sign in to unlock the full Citius Oncology Inc balance sheet history.

About Citius Oncology Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-090184

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.